Transition from “old” injected drugs to mephedrone in an urban micro segregate in Budapest, Hungary: a qualitative analysis

References

• Beyrer, C., Malinowska-Sempruch, K., Kamarulzaman, A., Kazatchkine, M., Sidibe, M., & Strathdee, S. A. (2010). Time to act: A call for comprehensive responses to HIV in people who use drugs. Lancet, 376, 551–563
   PubMed Web of Science ®Google Scholar
• Brain, H. P., & Tom Carnwath, K. (2000). Drinking with design: Young drinkers as psychoactive consumers. Drugs: Education, Prevention, and Policy, 7, 5–20
   Web of Science ®Google Scholar
• Brown, N. L., Luna, V., Ramirez, M. H., Vail, K. A., & Williams, C. A. (2005). Developing an effective intervention for IDU women: A harm reduction approach to collaboration. AIDS Education Prevention, 17, 317–333
   PubMed Web of Science ®Google Scholar
• Burris, S., Blankenship, K. M., Donoghoe, M., Sherman, S., Vernick, J. S., Case, P., Lazzarini, Z., & Koester, S. (2004). Addressing the “risk environment” for injection drug users: The mysterious case of the missing cop. Milbank Q, 82, 125–156
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 118, 19–22
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Vlahov, D., Cohn, S., Anthony, J. C., Solomon, L., & Nelson, K. E. (1991). Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal of Public Health, 81, 1291–1295
   PubMed Web of Science ®Google Scholar
• Csák, R. (2011). Characteristics of needle exchange clientele at Blue Point Drug Counselling and Outpatient Centre [Manuscript]. Unpublished manuscript, Budapest
   Google Scholar
• Csák, R., Gyékiss, R., Márványkövi, F., Vadász, V., & Rácz, J. (2010). Magyarországi intravénás mefedronhasználat a tűcsere szolgáltatók tapasztalatai alapján. [Hungarian injecting mephedrone use based on perceptions of needle exchnge staffs.] Addiktológia, 9, 281–288
   Google Scholar
• Dargan, P. I., Albert, S., & Wood, D. M. (2010). Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM, 103, 875–879
   PubMed Web of Science ®Google Scholar
• Duff, C. (2007). Towards a theory of drug use contexts: Space, embodiment and practice. Addiction Research & Theory, 15, 503–519
   Web of Science ®Google Scholar
• Duff, C. (2008). The pleasure in context. The International Journal on Drug Policy, 19, 384–392
   PubMed Web of Science ®Google Scholar
• Duff, C. (2009). The drifting city: The role of affect and repair in the development of “Enabling Environments”. International Journal of Drug Policy, 20, 202–208
   PubMed Web of Science ®Google Scholar
• Dunn, J., & Ferri, C. P. (1999). Epidemiological methods for research with drug misusers: Review of methods for studying prevalence and morbidity. Revista de Saúde Pública, 33, 206–215
   PubMed Web of Science ®Google Scholar
• EMCDDA. (2010). Risk assessment report of a new psychoactive substance: 4-Methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction
   Google Scholar
• Evans, K. (2007). Concepts of bounded agency in education, work, and the personal lives of young adults. International Journal of Psychology, 42, 85–93
   Web of Science ®Google Scholar
• Ezard, N. (2001). Public health, human rights and the harm reduction paradigm: From risk reduction to vulnerability reduction. International Journal of Drug Policy, 12, 207–219
   Google Scholar
• Fast, D., Small, W., Krusi, A., Wood, E., & Kerr, T. (2010). ‘I guess my own fancy screwed me over’: Transitions in drug use and the context of choice among young people entrenched in an open drug scene. BMC Public Health, 10, 126
   Google Scholar
• Fast, D., Small, W., Wood, E., & Kerr, T. (2009). Coming ‘down here’: young people's reflections on becoming entrenched in a local drug scene. Social Science & Medicine, 69, 1204–1210
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Jose, B., Deren, S., Des Jarlais, D. C., & Neaigus, A. (1995). Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium. American Journal of Epidemiology, 142, 864–874
   PubMed Web of Science ®Google Scholar
• Gyarmathy, V., Neaigus, A., Ujhelyi, E., Szabó, T., & Rácz, J. (2006). Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors. Drug and Alcohol Dependence, 82, 65–69
   Google Scholar
• Gyarmathy, V., Ujhelyin, E., & Neaigus, A. (2008). HIV and selected blood-borne and sexually transmitted infections in a predominantly Roma (Gypsy) neighbourhood in Budapest, Hungary: A rapid assessment. Central European Journal of Public Health, 16, 124–127
   PubMedGoogle Scholar
• Gyarmathy, V. A., & Neaigus, A. (2005). Marginalized and socially integrated groups of IDUs in Hungary: Potential bridges of HIV infection. Journal of Urban Health, 82, iv101–iv112
   PubMed Web of Science ®Google Scholar
• Haines, R. J., Poland, B. D., & Johnson, J. L. (2009). Becoming a ‘real’ smoker: Cultural capital in young women's accounts of smoking and other substance use. Sociology of Health and Illness, 31, 66–80
   PubMed Web of Science ®Google Scholar
• Harocopos, A., Goldsamt, L. A., Kobrak, P., Jost, J. J., & Clatts, M. C. (2009). New injectors and the social context of injection initiation. International Journal of Drug Policy, 20, 317–323
   PubMed Web of Science ®Google Scholar
• Harris, M., & Rhodes, T. (2013). Injecting practices in sexual partnerships: Hepatitis C transmission potentials in a ‘risk equivalence’ framework. Drug and Alcohol Dependence, 132, 617–623
   PubMed Web of Science ®Google Scholar
• Hser, Y. I., Longshore, D., & Anglin, M. D. (2007). The life course perspective on drug use: A conceptual framework for understanding drug use trajectories. Evaluation Review, 31, 515–547
   PubMed Web of Science ®Google Scholar
• Kapitany-Foveny, M., Kertesz, M., Winstock, A., Deluca, P., Corazza, O., Farkas, J., Zacher, G., Urbán, R., & Demetrovics, Zs. (2013). Substitutional potential of mephedrone: An analysis of the subjective effects. Human Psychopharmacology, 28, 308–316
   Google Scholar
• Kerr, T., Small, W., & Wood, E. (2005). The public health and social impacts of drug market enforcement: A review of the evidence. International Journal of Drug Policy, 16, 210–220
   Web of Science ®Google Scholar
• KSH [Hungarian Central Statistical Office]. (2001). Country report. Budapest: Központi Statisztikai Hivatal
   Google Scholar
• Kuebler, D., & Hausser, D. (1997). The Swiss Hidden Population Study: Practical and methodological aspects of data collection by privileged access interviewers. Addiction, 92, 325–334
   PubMed Web of Science ®Google Scholar
• Ladányi, J. (1989). A lakásrendszer változásai és a cigány népesség térbeni elhelyezkedésének átalakulása Budapesten. [Changes of the situation of housing and the placement of Roma communities in Budapest]. Valóság, 32(8), 79–89
   Google Scholar
• Ladányi, J. (1992). Gondolatok a Középső-Józsefváros rehabilitációjának társadalmi összefüggéseiről. [Thinking about the social consequences of city rehabilitation in Central Józsefváros]. Tér és Társadalom, 6(3–4), 75–88
   Google Scholar
• Ladányi, J. (2004). Társadalmi és etnikai csoportok közötti lakóhelyi szegregáció Budapesten a posztkommunista átment időszakában. [Housing segregation of social and ethnical groups in Budapest during the postcommunist transition]. Web, (13), 9–16
   Google Scholar
• Latkin, C. A., Forman, V., Knowlton, A., & Sherman, S. (2003). Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Social Science & Medicine, 56, 465–476
   PubMed Web of Science ®Google Scholar
• Lovell, A. M. (2002). Risking risk: The influence of types of capital and social networks on the injection practices of drug users. Social Science & Medicine, 55, 803–821
   PubMed Web of Science ®Google Scholar
• Lupton, D. (1999). Risk. London: Routledge
   Google Scholar
• Lupton, D., & Tulloch, J. (2002). ‘Life would be pretty dull without risk’: Voluntary risk-taking and its pleasures. Health, Risk & Society, 4, 113–124
   Web of Science ®Google Scholar
• MacLean, S. (2008). Volatile bodies: Stories of corporeal pleasure and damage in marginalised young people's drug use. International Journal of Drug Policy, 19, 375–383
   PubMed Web of Science ®Google Scholar
• Maher, L., & Dixon, D. (1999). Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39, 488–512
   Web of Science ®Google Scholar
• Márványkövi, F., Melles, K., Légmán, A., & Rácz, J. (2008). A kezelésbe jutás akadályai roma és nem roma, kezelésen kívüli intravénás használók körében, Budapesten. [Barriers to treatment among Roma and non-Roma injecting drug users]. Addiktológia, 7, 205–233
   Google Scholar
• Mathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., Myers, B., Ambekar, A., & Strathdee, S. A., et al. (2010). HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. The Lancet, 375, 1014–1028
   PubMed Web of Science ®Google Scholar
• Mayock, P. (2005). ‘Scripting’ risk: Young people and the construction of drug journeys. Drugs: Education, Prevention and Policy, 12, 349–368
   Web of Science ®Google Scholar
• McElrath, K., & O'Neill, C. (2011). Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy, 22, 120–127
   PubMed Web of Science ®Google Scholar
• Measham, F., Moore, K., Newcombe, R., & Zoë, N. S. (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10, 14–21
   Google Scholar
• Moore, D., & Dietze, P. (2005). Enabling environments and the reduction of drug-related harm: Re-framing Australian policy and practice. Drug and Alcohol Review, 24, 275–284
   PubMed Web of Science ®Google Scholar
• Neaigus, A., Miller, M., Friedman, S. R., Hagen, D. L., Sifaneck, S. J., Ildefonso, G., & des Jarlais, D. C., et al. (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction, 96, 847–860
   PubMed Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L., (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378, 571–583
   PubMed Web of Science ®Google Scholar
• Newcombe, R. (2009). The Use of Mephedrone (M-cat, Meow) in Middlesbrough. Manchester, UK: Lifeline Publications and Research
   Google Scholar
• Parkin, S., & Coomber, R. (2011). Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): A Lefebvrian analysis. Health Place, 17, 717–726
   PubMed Web of Science ®Google Scholar
• Parkin, S., Coomber, R., & Wallace, G. (2010). Going public. Drink and Drug News, February, 14--15. ISSN 2164-8050. Available from: http://drinkanddrugsnews.com/wp-content/uploads/2012/12/DDNfeb10.pdf
   Google Scholar
• Rácz, J., Márványkövi, F., Melles, K., & Vadász, V. (2010). Út a túléléshez. Nyílt színi droghasználat és “belövőszobák” Budapesten. Az ártalomcsökkentéssel kapcsolatos megfontolások. [Road to survival. Open drug scene and shooting galleries in Budapest. Considerations on harm reduction]. Budapest: L'Harmattan
   Google Scholar
• Rhodes, T. (2002). The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13, 85–94
   Google Scholar
• Rhodes, T., Bivol, S., Scutelniciuc, O., Hunt, N., Bernays, S., & Busza, J. (2011). Narrating the social relations of initiating injecting drug use: Transitions in self and society. International Journal of Drug Policy, 22, 445–454
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C. M., Rylkov, A., Khutorskoy, M., & Renton, A. (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science & Medicine, 57, 39–54
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science & Medicine, 61, 1026–1044
   PubMed Web of Science ®Google Scholar
• RNDFP (Reitox National Drug Focal Point). (2010). National Report to the EMCDDA. “Hungary” New developments, trends and in-depth information on selected issues. Budapest: Reitox National Drug Focal Point
   Google Scholar
• RNDFP (Reitox National Drug Focal Point). (2011). National Report to the EMCDDA. “Hungary” New developments, trends and in-depth information on selected issues. Budapest: Reitox National Drug Focal Point
   Google Scholar
• RNDFP (Reitox National Drug Focal Point). (2012). National Report to the EMCDDA. “Hungary” New developments, trends and in-depth information on selected issues. Budapest: Reitox National Focal Point
   Google Scholar
• Roy, E., Nonn, E., & Haley, N. (2008). Transition to injection drug use among street youth—A qualitative analysis. Drug and Alcohol Dependence, 94, 19–29
   PubMed Web of Science ®Google Scholar
• Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P., Corazza, O., Davey, Z., Corkery, J., Siemann, H., Scherbaum, N., Farre’, M., Torrens, M., Demetrovics, Zs. & Ghodse, A. H., Psychonaut Web Mapping, ReDNet Research Groups. (2011). Mephedrone (4-methylmethcathinone; ‘meow meow’): Chemical, pharmacological and clinical issues. Psychopharmacology (Berlin), 214, 593–602
   PubMed Web of Science ®Google Scholar
• Schifano, F., Ricciardi, A., Corazza, O., Deluca, P., Davey, Z., & Rafanelli, C. (2010). New drugs of abuse on the Web: The role of the Psychonaut Web Mapping Project. Rivista di Psichiatria, 45, 88–93
   PubMed Web of Science ®Google Scholar
• Seth, P., Murray, C. C., Braxton, N. D., & DiClemente, R. J. (2013). The concrete jungle: City stress and substance abuse among young adult African American men. Journal of Urban Health, 90, 307–313
   Google Scholar
• Shannon, K., Rusch, M., Shoveller, J., Alexson, D., Gibson, K., & Tyndall, M. W. (2008). Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. International Journal of Drug Policy, 19, 140–147
   PubMed Web of Science ®Google Scholar
• Ssewamala, F. M., Sperber, E., Blake, C. A., & Ilic, V. P. (2012). Increasing opportunities for inner-city youth: The feasibility of an economic empowerment model in east Harlem and the South Bronx, New York. Children and Youth Services Review, 34, 218–224
   Google Scholar
• Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010). HIV and risk environment for injecting drug users: The past, present, and future. Lancet, 376, 268–284
   PubMed Web of Science ®Google Scholar
• Sulkunen, P. (2002). Between culture and nature: Intoxication in cultural studies of alcohol and drug use. Contemporary Drug Problems, 29, 253–276
   Google Scholar
• Thorpe, L. E., Bailey, S. L., Huo, D., Monterroso, E. R., & Ouellet, L. J. (2001). Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997–1999). Journal of Acquired Immune Deficiency Syndrome, 27, 71–78
   Google Scholar
• Tóth, A. R., Hideg, Z., & Institóris, L. (2011). Egy régi-új kábítószer – A mefedron. Orvosi Hetilap, 152, 1192–1196
   PubMedGoogle Scholar
• Van Hout, M. C., & Bingham, T. (2012). “A costly turn on”: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy, 23, 188–197
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 19, 156–162
   Web of Science ®Google Scholar
• Vardakou, I., Pistos, C., & Spiliopoulou, C. (2011). Drugs for youth via Internet and the example of mephedrone. Toxicology Letters, 201, 191–195
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., & Marsden, J. (2010). Mephedrone: Assessment of health risks and harms, European Monitoring Centre for Drugs and Drug Addiction. Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: EMCDDA
   Google Scholar
• Winstock, A. R., Mitcheson, L., & Marsden, J. (2010a). Mephedrone: Still available and twice the price. Lancet, 376, 1537
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Marsden, J., & Mitcheson, L. (2010b). What should be done about mephedrone? British Medical Journal, 340, c1605
   PubMed Web of Science ®Google Scholar
• Winstock, A., Mitcheson, L., Ramsey, J., Davies, S., Puchnarewicz, M., & Marsden, J. (2011a). Mephedrone: Use, subjective effects and health risks. Addiction, 106, 1991–1996
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Mitcheson, L. R., Deluca, P., Davey, Z., Corazza, O., & Schifano, F. (2011b). Mephedrone, new kid for the chop? Addiction, 106, 154–161
   PubMed Web of Science ®Google Scholar
• Wood, D. M., Greene, S. L., & Dargan, P. I. (2013). Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: Mephedrone (4-methylmethcathinone) control appears to be effective using this model. Emergency Medicine Journal, 30, 70–71
   PubMed Web of Science ®Google Scholar